April 2008

 

Issue

CHIEF MEDICAL EDITOR'S PAGE

Noninterventional and Medical PAD Management

By John R. Laird, Jr, MD with Michael R. Jaff, DO, FACP, FACC, FAHA

FEATURED TECHNOLOGY

Sponsored by Cardiva Medical, Inc.

Hemostasis: Can We Do Better Than the Gold Standard?

Vascular closure devices can provide reliable and safe hemostasis at the arteriotomy site.

By Klaus Tiroch, MD, PhD, and Bernadette Longo, PhD

CHALLENGING CASES

Treating Complex SFA Occlusive Disease

Two case reports detailing the use of the Viabahn endoprosthesis with heparin bioactive surface.

By Donald T. Baril, MD; Luke K. Marone, MD; and Mark H. Wholey, MD

VESSEL UPDATE: THORACIC AORTA

Thoracic Endograft Performance Evaluations

Insights shared at the 2007 Cleveland Clinic Stent Summit.

By Robert G. Whirley, PhD; Mike Nilson, BS; Catherine Szyman, MBA; Matthew S. Waninger, PhD; and Roy K. Greenberg, MD

TECHNIQUES

Do We Really Need a New Varicose Vein Technique?

A hybrid embolization technique involving occlusion coils and alcohol sclerosis.

By Michel K. Barsoum, MB, ChB; Thom W. Rooke, MD; and Haraldur Bjarnason, MD

COVER STORY

Therapeutic Choice Is Quality Claudication Care

Exercise and claudication pharmacotherapies as the foundation to redefine conservative care.

By Mudassar Ahmed, MD; Sara Murray, MD; and Alan T. Hirsch, MD

Hypertension Management in PAD Patients

Optimal medical management.

By James A.M. Smith, DO

Prasugrel and Clopidogrel: What Will Their Roles Be?

An editorial on what recent clinical trials have shown us about new antiplatelet agents.

By Bruce H. Gray, DO

Advances in Gene Therapy

Brian H. Annex, MD, a pioneer in angiogenesis research, discusses the current state of this investigative field, methods for delivery of agents, and areas of ongoing research, including a very recent genetic study in the area of peripheral arterial disease.

Stem Cell Therapy for Peripheral Arterial Disease

Leading researcher Douglas W. Losordo, MD, discusses the recent progress and future directions of this promising therapy.

By Douglas W. Losordo, MD

SOCIETY UPDATE

The Evolution of Vascular Surgery

Endovascular Today interviews Giorgio M. Biasi, MD, President of the ISVS, who discusses the worldwide mission of the society and the state of vascular surgery.

An Interview with Thomas A. Sos, MD

An expert on renal artery therapy discusses when intervention is appropriate, the best methods for diagnosis, and some of the shortcomings of prospective, randomized studies of renal therapies.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.